[Genetic mutations in malignant lymphoma: the molecular and clinical significances and the application for development of molecular targeting therapeutics].
Akihiro
A
Tomita
D000818:Animals; D044127:Epigenesis, Genetic; D020022:Genetic Predisposition to Disease; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis / Q000235:genetics* / Q000628:therapy*; D058990:Molecular Targeted Therapy / Q000379:methods; D009154:Mutation / Q000235:genetics*; D017346:Protein Serine-Threonine Kinases / Q000235:genetics / Q000378:metabolism; D000097782:NF-kappaB-Inducing Kinase
D017346:Protein Serine-Threonine Kinases; D000097782:NF-kappaB-Inducing Kinase